Advertisement
Home »

First Effective First-Line Chemo/Immunotherapy Combo for Urothelial Cancer

Nov 02, 2023

REFERENCES & ADDITIONAL READING

Powles TB, Csőszi T, Özgüroğlu M, et al. Lancet Oncol. 2021;22(7):931-945. DOI: 10.1016/S1470-2045(21)00152-2

 

Galsky MD, Arranz Arija JA, Bamias A, et al. Lancet. 2020;395(10236):1547-1557. DOI: 10.1016/S0140-6736(20)30230-0

 

Van der Heijden MS, Sonpavde G, Powles T, et al. Nivolumab plus gemcitabine-cisplatin versus gemcitabine-cisplatin alone for previously untreated unresectable or metastatic urothelial carcinoma: Results from the phase III CheckMate 901 trial. Abstract LBA7, ESMO 2023, 20-24 October, Madrid, Spain.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement